Latest SPAC Liquidations: VMG Consumer, Evo, Banner, and XPAC
VMG Consumer Acquisition Corp. (VMGA) to Liquidate on May 15
VMG Consumer Acquisition Corp. (NASDAQ:VMGA) today announced that it has cancelled its special meeting of stockholders and intends to dissolve and liquidate, effective as of the close of business on May 15, 2023. It will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering, at a per-share redemption price of approximately $10.40.
READEvo Acquisition Corp. (EVOJ) to Liquidate on May 8
Evo Acquisition Corp. (Nasdaq: EVOJ) announced, announced today that it intends to liquidate as soon as practicable on or after May 8, and to return funds to holders of its shares of Class A common stock.
In view of the previously announced termination of Evo’s Business Combination Agreement with 20Cube Logistics Pte. Ltd. and certain other parties, the Board of Directors of Evo has determined not to further extend the deadline date in which Evo is required to consummate a business combination beyond the current expiration date, May 8, 2023.
After satisfying its liabilities for expenses and working capital loans, Evo expects to redeem all of its outstanding shares of Class A common stock for an estimated redemption price of approximately $10.12 per share after the payment of taxes and dissolution expenses. On or about the close of business on May 9, the Class A common stock will be deemed canceled and will represent only the right to receive the redemption amount.
READBanner Acquisition Corp. (BNNR) to Liquidate on May 16
Banner Acquisition Corp. (NASDAQ: BNNR) today announced that it will redeem all of its outstanding shares of Class A common stock, effective as of the close of business on or around May 16.
The per-share redemption price for the public shares will be approximately $10.27.
READXPAC Acquisition Corp. (XPAX) Terminates Deal, Announces Possible Liquidation
On May 2, SuperBac informed XPAC (NASDAQ:XPAX) that it had decided to terminate the business combination agreement. SuperBac disclosed that it terminated the deal for a number of reasons including the prevailing unfavorable public market conditions and trends in the share price performance of companies that have completed de-SPAC transactions, a balancing of the benefits and drawbacks of becoming a publicly traded company under current circumstances, and the fact that no PIPE investments had been entered.
In connection with the termination of the deal, the XPAC Board determined that it is very unlikely that it would able to complete an initial business combination with a target other than SuperBac before the termination date and that it is in the best interests of XPAC and its shareholders to accelerate the deadline. If the accelerated termination shareholder matters are approved, then the SPAC will liquidate.
READ
Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this afternoon that it has come to a forward purchase agreement (FPA) with Meteora Capital Partners involving up to 2,500,000 shares for its combination with NKGen Biotech. Meteora is to purchase up to that amount on the open market prior to close, capped at 9.9% of...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Heard on the Street: VinFast’s SPAC Backers Are Backing Out Even by the standards of electric-vehicle startups, the $40 billion market value of Vietnamese electric-vehicle startup VinFast is wild, following its combination with Black Spade last month....
Murphy Canyon (NASDAQ:MURF) announced this morning that it has closed its combination with Conduit Pharmaceuticals and its shares and warrants are expected to begin trading on the Nasdaq under the symbols “CDT” and “CDTTW” on September 25. The company also closed a purchase of $20 million in Murphy Canyon units at close, which is to...
Indie Semiconductor (NASDAQ:INDI), which merged with Thunder Bridge II in June 2021, announced this morning that it has launched an exchange offer to convert each outstanding warrant to 0.285 Class A shares in the company. At Indie’s last closing price of $6.22, this is $1.77 of value each, although the stock has been rising since...
Atlantic Coastal II (NASDAQ:ACAB) has entered into a definitive agreement to combine with drug developer Abpro at a valuation of $725 million. Woburn, Massachusetts-based Abpro is advancing a series of drug candidates to potentially treat COVID, cancer and diabetic blindness. The combined company is expected to trade on the Nasdaq once the deal is completed...